100 VANGUARD BOULEVARD,
MALVERN , PA, 19355
MALVERN , PA, 19355
Summary
The fund seeks to track the total return performance of a benchmark index before fees and expenses by investing in companies across any size in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
The process employs an indexing investment approach to track the per More
Link
Directors
Nov 14, 2023- Tara Bunch
- Emerson U. Fullwood
- Grant Reid
- David Thomas
- Peter F. Volanakis
- F. Joseph Loughrey
- Mortimer J. Buckley
- Deanna Mulligan
- Andre F. Perold
- Sarah Bloom Raskin
- Mark Loughridge
- Scott C. Malpass
Chief Compliance Officer
- Jacqueline Angell
Fund Manager(s)
Price
- 52-Week High/Low
- $144.14 - $113.24
- Turnover
- 4.8%
- Expense Ratio
- 0.10%
Company Name |
Holding |
| Eli Lilly & Co | 11 % |
| UnitedHealth Group Inc | 7.62 % |
| Johnson & Johnson | 5.8 % |
| Merck & Co Inc | 5.29 % |
| AbbVie Inc | 4.73 % |
| Thermo Fisher Scientific Inc | 3.65 % |
| Danaher Corp | 3 % |
| Abbott Laboratories | 2.95 % |
| Amgen Inc | 2.72 % |
| Pfizer Inc | 2.69 % |
| More | 2.69 % |
Documents
Performance
YTD
0.9%
3 Year
4.95%
5 Year
53.94%
Best
42.67%
2013
Worst
-23.52%
2008
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 8% | -3.9% | -4.4% | 1.5% | -13.4% | 8.2% | -0.3% | 9.1% | -6.9% | 7.8% |
| Q2 | -5.1% | 2.7% | -7.5% | 9.5% | 16% | 0.7% | 6.7% | 7.4% | 6.1% | 3.4% |
| Q3 | - | -4.1% | -5.1% | -0.9% | 4.8% | -4.1% | 13.2% | 3.7% | 2.3% | -11.6% |
| Q4 | - | 7% | 11.1% | 8% | 10.1% | 14.4% | -10.9% | 0.5% | -4.3% | 8.8% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2.4% | 3.5% | 1.9% | -5.9% | - | - | - | - | - | - | - | - |
| 2023 | -0.8% | -4.5% | 1.5% | 3% | -4% | 3.9% | 1% | -1.2% | -3.9% | -3.9% | 5.7% | 5.1% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1% | 1% | -7% | 19% | 17% | 20% | 6% | 23% | -3% | 7% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| VHCIX | 1% | 1% | -7% | 19% | 17% | 20% | 6% | 23% | -3% | 7% |
| S&P 500 | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% | -1% |
| Alpha | 1% | 1% | 14% | -8% | 0% | -9% | 12% | 4% | -13% | 8% |